Fundraising Fox
Pace Surgical
Malvern, US · Founded 2023 · Delaware corporation
Find your way into Pace Surgical
Sign up to see every warm intro you have to Pace Surgical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pace Surgical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pace Surgical develops anatomically specific foot and ankle trauma and reconstruction devices designed by surgeons, including its Ultra Compression Screw System and Tempo Variable Locking Plating technologies. The products target foot and ankle surgeons in podiatry and orthopedic trauma care and are not yet FDA cleared.
Founders & leadership
WS
William Scott RhodaExecutive
JO
Jeffrey O'Donnell, Jr.Co-Founder, Chief Executive Officer, and Board MemberJeffrey O'Donnell Jr. is an executive leading Pace Surgical and other medical device portfolio companies through product development and FDA regulatory processes, with over fifteen years of experience in musculoskeletal device commercialization; he holds degrees from Saint Joseph's University and serves as Chief Operating Officer of Runway Investment Management and a General Partner at MAST Labs surgical training.
JF
Jeffrey F. O'Donnell, Sr.Executive
WJ
William John OdenthalNamed on SEC filing
Board
MW
Michael WestBoard director
NP
Nicholas PachudaBoard director
Reported raises · per SEC filings
Form D private placements$4.9M disclosed across 5 rounds · 2023–2025
▶$1.5MraisedFeb 2026 · 11 investors · Other Health CareRule 506(b)
▶$1.5MraisedFeb 2026 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas PachudaDirector
- Harry Thomas Hall, IVDirector
- Jeffrey F. O'Donnell, Sr.Executive Officer, Director
- William Scott RhodaExecutive Officer, Director
- Jeffrey O'Donnell, Jr.Executive Officer, Director
- Offering amount
- $1.6M
- Amount sold
- $1.5M
- Sales commissions
- $38.1K
- Proceeds to insiders
- $200K
- Placement agents
- "Alere Financial Partners, A division of Cova Capital Partners LLC (""Alere""))"
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$1.2MraisedJul 2025 · 15 investors · Other Health CareRule 506(b)
▶$1.2MraisedJul 2025 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffery O'Donnell, Jr.Executive Officer, Director
- William Scott RhodaExecutive Officer, Director
- Jeffrey F. O'Donnell, Sr.Executive Officer, Director
- Harry Thomas Hall, IVDirector
- Nicholas PachudaDirector
- Offering amount
- $1.3M
- Amount sold
- $1.2M
- Sales commissions
- $35.7K
- Proceeds to insiders
- $160K
- Placement agents
- "Alere Financial Partners, A division of Cova Capital Partners LLC (""Alere""))"
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$765KraisedSep 2024 · 10 investors · Other Health CareRule 506(b)
▶$765KraisedSep 2024 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael WestDirector
- Nicholas PachudaDirector
- William Scott RhodaExecutive Officer, Director
- Jeffrey O'Donnell, Jr.Executive Officer, Director
- Jeffrey F. O'Donnell, Sr.Executive Officer, Director
- Offering amount
- $1.6M
- Amount sold
- $765K
- Sales commissions
- $46.4K
- Proceeds to insiders
- $150K
- Placement agents
- "Alere Financial Partners, A Division of Cova Capital Partners LLC (""Alere"")"
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$1MraisedMar 2024 · 1 investors · Other Health CareRule 506(b)
▶$1MraisedMar 2024 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey F. O'Donnell, Jr.Executive Officer, Director
- Michael WestDirector
- Nicholas PachudaDirector
- William Scott RhodaExecutive Officer, Director
- Jeffrey F. O'Donnell, Sr.Executive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Proceeds to insiders
- $350K
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$400KraisedAug 2023 · 1 investors · Other Health CareRule 506(b)
▶$400KraisedAug 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey F. O'Donnell, Sr.Executive Officer, Director
- William Scott RhodaExecutive Officer, Director
- William John OdenthalExecutive Officer, Director
- Jeffrey F. O'Donnell, Jr.Executive Officer, Director
- Offering amount
- $400K
- Amount sold
- $400K
- Proceeds to insiders
- $140K
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Pace Surgical do?
- Pace Surgical develops anatomically specific foot and ankle trauma and reconstruction devices designed by surgeons, including its Ultra Compression Screw System and Tempo Variable Locking Plating technologies. The products target foot and ankle surgeons in podiatry and orthopedic trauma care and are not yet FDA cleared.
- How much funding has Pace Surgical raised?
- Pace Surgical has disclosed $4.9M raised across 5 rounds.
- Where is Pace Surgical headquartered?
- Pace Surgical is headquartered in Malvern, US.